Rocket Pharmaceuticals (RCKT) Enterprise Value (2014 - 2026)
Rocket Pharmaceuticals (RCKT) reported Enterprise Value of -$239.2 million for Q1 2026, up 24.83% on a YoY basis from -$191.6 million in Q1 2025, and down 26.59% sequentially from -$188.9 million in Q4 2025.
Rocket Pharmaceuticals (RCKT) Enterprise Value (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 13 years of Enterprise Value data on file, last reported at -$239.2 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 24.83% year-over-year to -$239.2 million; the trailing twelve-month figure through Mar 2026 stood at -$239.2 million (up 24.83% YoY), and the FY2025 full-year result was -$188.9 million, up 49.26% from the prior year.
- Enterprise Value slipped to -$239.2 million in Q1 2026, from -$188.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$188.9 million in Q4 2025 to a low of -$648.7 million in Q3 2023.
- A 5-year average of -$387.7 million and a median of -$369.6 million in 2025 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 63.67% in 2024, while the deepest fall reached 69.04% in 2024.
- Tracing RCKT's Enterprise Value over 5 years: stood at -$356.4 million in 2022, then declined by 4.71% to -$373.2 million in 2023, then grew by 0.22% to -$372.3 million in 2024, then surged by 49.26% to -$188.9 million in 2025, then dropped by 26.59% to -$239.2 million in 2026.
- Business Quant data shows RCKT's Enterprise Value at -$239.2 million in Q1 2026, -$188.9 million in Q4 2025, and -$369.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Rocket Pharmaceuticals | 357.93 Mn | 357.93 Mn | - | -239.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -239.17 Mn |
| Dec 31, 2025 | -188.93 Mn |
| Sep 30, 2025 | -369.61 Mn |
| Jun 30, 2025 | -271.49 Mn |
| Mar 31, 2025 | -318.16 Mn |
| Dec 31, 2024 | -372.34 Mn |
| Sep 30, 2024 | -235.66 Mn |
| Jun 30, 2024 | -519.02 Mn |
| Mar 31, 2024 | -330.31 Mn |
| Dec 31, 2023 | -373.18 Mn |
| Sep 30, 2023 | -648.71 Mn |
| Jun 30, 2023 | -307.04 Mn |
| Mar 31, 2023 | -626.51 Mn |
| Dec 31, 2022 | -356.39 Mn |
| Sep 30, 2022 | -416.37 Mn |
| Jun 30, 2022 | -455.22 Mn |
| Mar 31, 2022 | -562.64 Mn |
| Dec 31, 2021 | -388.74 Mn |
| Sep 30, 2021 | -597.32 Mn |
| Jun 30, 2021 | -426.83 Mn |